PneumoNP partners will attend ECCMID 2017 in Vienna, Austria, from 22-25th April 2017.
ECCMID is a major event for experts of infectious diseases and clinical microbiology. A wide range of these topics will be discussed during symposia and poster sessions.
Several PneumoNP partners attend ECCMID 2017. They will present and discuss the latest results of the PneumoNP projects.
PathoFinder will have a company booth. They will display next generation multiplex PCR diagnostics kits for infectious diseases. One is under development in the framework of the PneumoNP project.
On Sunday 23rd, Alessandro Pini, from the company SetLance, will give a presentation during the session: Host-pathogen interactions provide opportunities for novel therapy. The session takes place in hall H from 11:30 to 12:30. His presentation will covers “the peptide SET-M33 as novel agent to neutralize and remove LPS in patients with sepsis”.
Meet us also during the session: New drugs against Gram-negatives. The session takes place in hall K on Monday 24th from 09:00 to 11:00. Chiara Falciani, from the company SetLance, will give a presentation entitled “An antimicrobial peptide to face multidrug-resistance emergency: synergies and mechanism of action underpinning efficacy”.